Detact Diagnostics

Delfzijl, Groningen, The Netherlands

+310615382382 ★

http://www.detactdiagnostics.com/

Company profile

Detact Diagnostics company profile

Detact holds the patent for a new, innovative, real-time, bacterial detection system that enables hospital staff to determine bacterial presence on surface areas with an easy to use system: the b-Swab.

Business identity

Website: http://www.detactdiagnostics.com/
Contact email: [email protected]
Phone number: +310615382382
Operating status: Active
Company type: For Profit
Employee range: 00001-00010 employees
Revenue range: $1K+
Founded: 2014-01-01

Headquarters

Headquarters: Delfzijl, Groningen, The Netherlands
Country code: NL
Continent: Europe

Capital profile

Funding and company signals

Funding rounds: 3
Total equity funding: $2.3M
Last funding: Grant / $5.9M / 2025-11-07
Last equity funding: Series Unknown
Investors: 4
Lead investors: 4
Founders: 1
Articles: 1

Categories and groups

Biotechnology Health Care Health Diagnostics Therapeutics Biotechnology Health Care Science and Engineering

Founders and investors

Founders

Joost Gazendam

Lead investors

Bill & Melinda Gates FoundationJM Molina InvestmentsNV NOMPacific 6 Enterprises

Investors

Bill & Melinda Gates FoundationJM Molina InvestmentsNV NOMPacific 6 Enterprises

People at this company

Preview only. Contact details are available after you sign in.

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Shipment records and coverage can change as the dataset is updated.